Lactylation Modification as a Promoter of Bladder Cancer: Insights from Multi-Omics Analysis
Bladder cancer (BLAC) is a malignant tumor with high morbidity and mortality. The establishment of a prognostic model for BLAC is of great significance for clinical prognosis prediction and treatment guidance. Lactylation modification is a newly discovered post-transcriptional modification of protei...
Saved in:
| Main Authors: | Yipeng He, Lingyan Xiang, Jingping Yuan, Honglin Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Current Issues in Molecular Biology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1467-3045/46/11/766 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The lactylation modification of proteins plays a critical role in tumor progression
by: Dehao Yi, et al.
Published: (2025-03-01) -
Characterization of lactylation modification subtypes and the promoting role of CCL20 in hepatocellular carcinoma progression
by: Li-Hong Wu, et al.
Published: (2025-07-01) -
Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer
by: Yuanqiao Zhao, et al.
Published: (2025-07-01) -
Identification of lactylation-associated immune and metabolic regulators in bladder cancer via integrated bulk and single-cell transcriptomics
by: Yanjun Chen, et al.
Published: (2025-07-01) -
H4K79 and H4K91 histone lactylation, newly identified lactylation sites enriched in breast cancer
by: Jiena Liu, et al.
Published: (2025-08-01)